Latest StemCyte Inc. Stories
COVINA, Calif., Oct. 25 /PRNewswire/ -- California-based StemCyte, Inc. is proud to announce a new strategic partnership with Sharp HealthCare, which includes California's largest birthing hospital, Sharp Mary Birch Hospital for Women & Newborns.
COVINA, Calif., April 8 /PRNewswire/ -- StemCyte, Inc. announces two recent events designed to position it for dynamic growth in its core business markets globally. First, StemCyte has promoted Calvin Cole to the newly formed position of President, StemCyte, North America.
COVINA, Calif., Nov. 30 /PRNewswire/ -- StemCyte, Inc. concluded an exclusive license and commercialization agreement with Academia Sinica, the National Laboratory of Taiwan, for certain proprietary methods and Intellectual Property (IP) related to the treatment of Chronic Stroke with stem cells.
COVINA, Calif., Oct. 22 /PRNewswire/ -- StemCyte, Inc., one of the world's preeminent cord blood banks and biotherapies companies, was recognized for its dramatic revenue growth as a Technology Fast 500(TM) award winner for 2009.
COVINA, Calif., Sept.
COVINA, Calif., May 28 /PRNewswire/ -- StemCyte, Inc., a privately held cord blood bank and stem cell therapeutics company, recently released their 1,000th cord blood stem cell shipment for transplant.
ARCADIA, Calif. and DUARTE, Calif., Nov. 8 /PRNewswire/ -- The National Marrow Donor Program (NMDP) has selected an abstract written by Dr. Auayporn Nademanee, physician and professor in the Division of Hematology & Hematopoietic Cell Transplantation at City of Hope, and Dr.
- To fire mitraille at.